Global Systemic Antifungals Supply, Demand and Key Producers, 2023-2029

Description

The global Systemic Antifungals market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Fungal infections are generally divided into superficial infections and deep infections (also known as systemic infections). Superficial fungal infections are often caused by various species of fungi, while deep fungal infections mainly affect internal organs and deep tissues, with a low incidence but a mortality rate of up to 50%. Antifungals are drugs that have the ability to inhibit or kill pathogenic fungi and are used to treat fungal infectious diseases.

Translated with www.DeepL.com/Translator (free version)
This report studies the global Systemic Antifungals demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Systemic Antifungals, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Systemic Antifungals that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Systemic Antifungals total market, 2018-2029, (USD Million)
Global Systemic Antifungals total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Systemic Antifungals total market, key domestic companies and share, (USD Million)
Global Systemic Antifungals revenue by player and market share 2018-2023, (USD Million)
Global Systemic Antifungals total market by Type, CAGR, 2018-2029, (USD Million)
Global Systemic Antifungals total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Systemic Antifungals market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MSD, Pfizer, Astellas Pharma, Gilead Sciences, Merck, Bayer, Novartis, Liposome Company and Xian-janssen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Systemic Antifungals market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Systemic Antifungals Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Systemic Antifungals Market, Segmentation by Type
    Injections
    Oral

Global Systemic Antifungals Market, Segmentation by Application
    Hospital
    Clinic
    Drugstores
    Others

Companies Profiled:
    MSD
    Pfizer
    Astellas Pharma
    Gilead Sciences
    Merck
    Bayer
    Novartis
    Liposome Company
    Xian-janssen
    CR Pharma
    Chiatai Tianqing
    Haisco Pharmaceutical
    Zhuhai Ebang Pharmaceutical
    Livzon Group Livzon Pharmaceutical Factory
    Honz Pharmaceutical
    Medisan
    Chengdu Brilliant Pharmaceutical

Key Questions Answered
1. How big is the global Systemic Antifungals market?
2. What is the demand of the global Systemic Antifungals market?
3. What is the year over year growth of the global Systemic Antifungals market?
4. What is the total value of the global Systemic Antifungals market?
5. Who are the major players in the global Systemic Antifungals market?

Table of Contents

1 Supply Summary
    1.1 Systemic Antifungals Introduction
    1.2 World Systemic Antifungals Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Systemic Antifungals Total Market by Region (by Headquarter Location)
        1.3.1 World Systemic Antifungals Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Systemic Antifungals Market Size (2018-2029)
        1.3.3 China Systemic Antifungals Market Size (2018-2029)
        1.3.4 Europe Systemic Antifungals Market Size (2018-2029)
        1.3.5 Japan Systemic Antifungals Market Size (2018-2029)
        1.3.6 South Korea Systemic Antifungals Market Size (2018-2029)
        1.3.7 ASEAN Systemic Antifungals Market Size (2018-2029)
        1.3.8 India Systemic Antifungals Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Systemic Antifungals Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Systemic Antifungals Major Market Trends

2 Demand Summary
    2.1 World Systemic Antifungals Consumption Value (2018-2029)
    2.2 World Systemic Antifungals Consumption Value by Region
        2.2.1 World Systemic Antifungals Consumption Value by Region (2018-2023)
        2.2.2 World Systemic Antifungals Consumption Value Forecast by Region (2024-2029)
    2.3 United States Systemic Antifungals Consumption Value (2018-2029)
    2.4 China Systemic Antifungals Consumption Value (2018-2029)
    2.5 Europe Systemic Antifungals Consumption Value (2018-2029)
    2.6 Japan Systemic Antifungals Consumption Value (2018-2029)
    2.7 South Korea Systemic Antifungals Consumption Value (2018-2029)
    2.8 ASEAN Systemic Antifungals Consumption Value (2018-2029)
    2.9 India Systemic Antifungals Consumption Value (2018-2029)

3 World Systemic Antifungals Companies Competitive Analysis
    3.1 World Systemic Antifungals Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Systemic Antifungals Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Systemic Antifungals in 2022
        3.2.3 Global Concentration Ratios (CR8) for Systemic Antifungals in 2022
    3.3 Systemic Antifungals Company Evaluation Quadrant
    3.4 Systemic Antifungals Market: Overall Company Footprint Analysis
        3.4.1 Systemic Antifungals Market: Region Footprint
        3.4.2 Systemic Antifungals Market: Company Product Type Footprint
        3.4.3 Systemic Antifungals Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Systemic Antifungals Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Systemic Antifungals Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Systemic Antifungals Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Systemic Antifungals Consumption Value Comparison
        4.2.1 United States VS China: Systemic Antifungals Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Systemic Antifungals Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Systemic Antifungals Companies and Market Share, 2018-2023
        4.3.1 United States Based Systemic Antifungals Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Systemic Antifungals Revenue, (2018-2023)
    4.4 China Based Companies Systemic Antifungals Revenue and Market Share, 2018-2023
        4.4.1 China Based Systemic Antifungals Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Systemic Antifungals Revenue, (2018-2023)
    4.5 Rest of World Based Systemic Antifungals Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Systemic Antifungals Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Systemic Antifungals Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Systemic Antifungals Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Injections
        5.2.2 Oral
    5.3 Market Segment by Type
        5.3.1 World Systemic Antifungals Market Size by Type (2018-2023)
        5.3.2 World Systemic Antifungals Market Size by Type (2024-2029)
        5.3.3 World Systemic Antifungals Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Systemic Antifungals Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Drugstores
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Systemic Antifungals Market Size by Application (2018-2023)
        6.3.2 World Systemic Antifungals Market Size by Application (2024-2029)
        6.3.3 World Systemic Antifungals Market Size by Application (2018-2029)

7 Company Profiles
    7.1 MSD
        7.1.1 MSD Details
        7.1.2 MSD Major Business
        7.1.3 MSD Systemic Antifungals Product and Services
        7.1.4 MSD Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 MSD Recent Developments/Updates
        7.1.6 MSD Competitive Strengths & Weaknesses
    7.2 Pfizer
        7.2.1 Pfizer Details
        7.2.2 Pfizer Major Business
        7.2.3 Pfizer Systemic Antifungals Product and Services
        7.2.4 Pfizer Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Pfizer Recent Developments/Updates
        7.2.6 Pfizer Competitive Strengths & Weaknesses
    7.3 Astellas Pharma
        7.3.1 Astellas Pharma Details
        7.3.2 Astellas Pharma Major Business
        7.3.3 Astellas Pharma Systemic Antifungals Product and Services
        7.3.4 Astellas Pharma Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Astellas Pharma Recent Developments/Updates
        7.3.6 Astellas Pharma Competitive Strengths & Weaknesses
    7.4 Gilead Sciences
        7.4.1 Gilead Sciences Details
        7.4.2 Gilead Sciences Major Business
        7.4.3 Gilead Sciences Systemic Antifungals Product and Services
        7.4.4 Gilead Sciences Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Gilead Sciences Recent Developments/Updates
        7.4.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.5 Merck
        7.5.1 Merck Details
        7.5.2 Merck Major Business
        7.5.3 Merck Systemic Antifungals Product and Services
        7.5.4 Merck Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Merck Recent Developments/Updates
        7.5.6 Merck Competitive Strengths & Weaknesses
    7.6 Bayer
        7.6.1 Bayer Details
        7.6.2 Bayer Major Business
        7.6.3 Bayer Systemic Antifungals Product and Services
        7.6.4 Bayer Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Bayer Recent Developments/Updates
        7.6.6 Bayer Competitive Strengths & Weaknesses
    7.7 Novartis
        7.7.1 Novartis Details
        7.7.2 Novartis Major Business
        7.7.3 Novartis Systemic Antifungals Product and Services
        7.7.4 Novartis Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Novartis Recent Developments/Updates
        7.7.6 Novartis Competitive Strengths & Weaknesses
    7.8 Liposome Company
        7.8.1 Liposome Company Details
        7.8.2 Liposome Company Major Business
        7.8.3 Liposome Company Systemic Antifungals Product and Services
        7.8.4 Liposome Company Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Liposome Company Recent Developments/Updates
        7.8.6 Liposome Company Competitive Strengths & Weaknesses
    7.9 Xian-janssen
        7.9.1 Xian-janssen Details
        7.9.2 Xian-janssen Major Business
        7.9.3 Xian-janssen Systemic Antifungals Product and Services
        7.9.4 Xian-janssen Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Xian-janssen Recent Developments/Updates
        7.9.6 Xian-janssen Competitive Strengths & Weaknesses
    7.10 CR Pharma
        7.10.1 CR Pharma Details
        7.10.2 CR Pharma Major Business
        7.10.3 CR Pharma Systemic Antifungals Product and Services
        7.10.4 CR Pharma Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 CR Pharma Recent Developments/Updates
        7.10.6 CR Pharma Competitive Strengths & Weaknesses
    7.11 Chiatai Tianqing
        7.11.1 Chiatai Tianqing Details
        7.11.2 Chiatai Tianqing Major Business
        7.11.3 Chiatai Tianqing Systemic Antifungals Product and Services
        7.11.4 Chiatai Tianqing Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Chiatai Tianqing Recent Developments/Updates
        7.11.6 Chiatai Tianqing Competitive Strengths & Weaknesses
    7.12 Haisco Pharmaceutical
        7.12.1 Haisco Pharmaceutical Details
        7.12.2 Haisco Pharmaceutical Major Business
        7.12.3 Haisco Pharmaceutical Systemic Antifungals Product and Services
        7.12.4 Haisco Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Haisco Pharmaceutical Recent Developments/Updates
        7.12.6 Haisco Pharmaceutical Competitive Strengths & Weaknesses
    7.13 Zhuhai Ebang Pharmaceutical
        7.13.1 Zhuhai Ebang Pharmaceutical Details
        7.13.2 Zhuhai Ebang Pharmaceutical Major Business
        7.13.3 Zhuhai Ebang Pharmaceutical Systemic Antifungals Product and Services
        7.13.4 Zhuhai Ebang Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Zhuhai Ebang Pharmaceutical Recent Developments/Updates
        7.13.6 Zhuhai Ebang Pharmaceutical Competitive Strengths & Weaknesses
    7.14 Livzon Group Livzon Pharmaceutical Factory
        7.14.1 Livzon Group Livzon Pharmaceutical Factory Details
        7.14.2 Livzon Group Livzon Pharmaceutical Factory Major Business
        7.14.3 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product and Services
        7.14.4 Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments/Updates
        7.14.6 Livzon Group Livzon Pharmaceutical Factory Competitive Strengths & Weaknesses
    7.15 Honz Pharmaceutical
        7.15.1 Honz Pharmaceutical Details
        7.15.2 Honz Pharmaceutical Major Business
        7.15.3 Honz Pharmaceutical Systemic Antifungals Product and Services
        7.15.4 Honz Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Honz Pharmaceutical Recent Developments/Updates
        7.15.6 Honz Pharmaceutical Competitive Strengths & Weaknesses
    7.16 Medisan
        7.16.1 Medisan Details
        7.16.2 Medisan Major Business
        7.16.3 Medisan Systemic Antifungals Product and Services
        7.16.4 Medisan Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.16.5 Medisan Recent Developments/Updates
        7.16.6 Medisan Competitive Strengths & Weaknesses
    7.17 Chengdu Brilliant Pharmaceutical
        7.17.1 Chengdu Brilliant Pharmaceutical Details
        7.17.2 Chengdu Brilliant Pharmaceutical Major Business
        7.17.3 Chengdu Brilliant Pharmaceutical Systemic Antifungals Product and Services
        7.17.4 Chengdu Brilliant Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023)
        7.17.5 Chengdu Brilliant Pharmaceutical Recent Developments/Updates
        7.17.6 Chengdu Brilliant Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Systemic Antifungals Industry Chain
    8.2 Systemic Antifungals Upstream Analysis
    8.3 Systemic Antifungals Midstream Analysis
    8.4 Systemic Antifungals Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Systemic Antifungals Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Systemic Antifungals Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Systemic Antifungals Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Systemic Antifungals Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Systemic Antifungals Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Systemic Antifungals Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Systemic Antifungals Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Systemic Antifungals Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Systemic Antifungals Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Systemic Antifungals Players in 2022
    Table 12. World Systemic Antifungals Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Systemic Antifungals Company Evaluation Quadrant
    Table 14. Head Office of Key Systemic Antifungals Player
    Table 15. Systemic Antifungals Market: Company Product Type Footprint
    Table 16. Systemic Antifungals Market: Company Product Application Footprint
    Table 17. Systemic Antifungals Mergers & Acquisitions Activity
    Table 18. United States VS China Systemic Antifungals Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Systemic Antifungals Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Systemic Antifungals Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Systemic Antifungals Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Systemic Antifungals Revenue Market Share (2018-2023)
    Table 23. China Based Systemic Antifungals Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Systemic Antifungals Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Systemic Antifungals Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Systemic Antifungals Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Systemic Antifungals Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Systemic Antifungals Revenue Market Share (2018-2023)
    Table 29. World Systemic Antifungals Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Systemic Antifungals Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Systemic Antifungals Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Systemic Antifungals Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Systemic Antifungals Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Systemic Antifungals Market Size by Application (2024-2029) & (USD Million)
    Table 35. MSD Basic Information, Area Served and Competitors
    Table 36. MSD Major Business
    Table 37. MSD Systemic Antifungals Product and Services
    Table 38. MSD Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. MSD Recent Developments/Updates
    Table 40. MSD Competitive Strengths & Weaknesses
    Table 41. Pfizer Basic Information, Area Served and Competitors
    Table 42. Pfizer Major Business
    Table 43. Pfizer Systemic Antifungals Product and Services
    Table 44. Pfizer Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Pfizer Recent Developments/Updates
    Table 46. Pfizer Competitive Strengths & Weaknesses
    Table 47. Astellas Pharma Basic Information, Area Served and Competitors
    Table 48. Astellas Pharma Major Business
    Table 49. Astellas Pharma Systemic Antifungals Product and Services
    Table 50. Astellas Pharma Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Astellas Pharma Recent Developments/Updates
    Table 52. Astellas Pharma Competitive Strengths & Weaknesses
    Table 53. Gilead Sciences Basic Information, Area Served and Competitors
    Table 54. Gilead Sciences Major Business
    Table 55. Gilead Sciences Systemic Antifungals Product and Services
    Table 56. Gilead Sciences Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Gilead Sciences Recent Developments/Updates
    Table 58. Gilead Sciences Competitive Strengths & Weaknesses
    Table 59. Merck Basic Information, Area Served and Competitors
    Table 60. Merck Major Business
    Table 61. Merck Systemic Antifungals Product and Services
    Table 62. Merck Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Merck Recent Developments/Updates
    Table 64. Merck Competitive Strengths & Weaknesses
    Table 65. Bayer Basic Information, Area Served and Competitors
    Table 66. Bayer Major Business
    Table 67. Bayer Systemic Antifungals Product and Services
    Table 68. Bayer Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Bayer Recent Developments/Updates
    Table 70. Bayer Competitive Strengths & Weaknesses
    Table 71. Novartis Basic Information, Area Served and Competitors
    Table 72. Novartis Major Business
    Table 73. Novartis Systemic Antifungals Product and Services
    Table 74. Novartis Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Novartis Recent Developments/Updates
    Table 76. Novartis Competitive Strengths & Weaknesses
    Table 77. Liposome Company Basic Information, Area Served and Competitors
    Table 78. Liposome Company Major Business
    Table 79. Liposome Company Systemic Antifungals Product and Services
    Table 80. Liposome Company Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Liposome Company Recent Developments/Updates
    Table 82. Liposome Company Competitive Strengths & Weaknesses
    Table 83. Xian-janssen Basic Information, Area Served and Competitors
    Table 84. Xian-janssen Major Business
    Table 85. Xian-janssen Systemic Antifungals Product and Services
    Table 86. Xian-janssen Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Xian-janssen Recent Developments/Updates
    Table 88. Xian-janssen Competitive Strengths & Weaknesses
    Table 89. CR Pharma Basic Information, Area Served and Competitors
    Table 90. CR Pharma Major Business
    Table 91. CR Pharma Systemic Antifungals Product and Services
    Table 92. CR Pharma Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. CR Pharma Recent Developments/Updates
    Table 94. CR Pharma Competitive Strengths & Weaknesses
    Table 95. Chiatai Tianqing Basic Information, Area Served and Competitors
    Table 96. Chiatai Tianqing Major Business
    Table 97. Chiatai Tianqing Systemic Antifungals Product and Services
    Table 98. Chiatai Tianqing Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Chiatai Tianqing Recent Developments/Updates
    Table 100. Chiatai Tianqing Competitive Strengths & Weaknesses
    Table 101. Haisco Pharmaceutical Basic Information, Area Served and Competitors
    Table 102. Haisco Pharmaceutical Major Business
    Table 103. Haisco Pharmaceutical Systemic Antifungals Product and Services
    Table 104. Haisco Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Haisco Pharmaceutical Recent Developments/Updates
    Table 106. Haisco Pharmaceutical Competitive Strengths & Weaknesses
    Table 107. Zhuhai Ebang Pharmaceutical Basic Information, Area Served and Competitors
    Table 108. Zhuhai Ebang Pharmaceutical Major Business
    Table 109. Zhuhai Ebang Pharmaceutical Systemic Antifungals Product and Services
    Table 110. Zhuhai Ebang Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Zhuhai Ebang Pharmaceutical Recent Developments/Updates
    Table 112. Zhuhai Ebang Pharmaceutical Competitive Strengths & Weaknesses
    Table 113. Livzon Group Livzon Pharmaceutical Factory Basic Information, Area Served and Competitors
    Table 114. Livzon Group Livzon Pharmaceutical Factory Major Business
    Table 115. Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Product and Services
    Table 116. Livzon Group Livzon Pharmaceutical Factory Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Livzon Group Livzon Pharmaceutical Factory Recent Developments/Updates
    Table 118. Livzon Group Livzon Pharmaceutical Factory Competitive Strengths & Weaknesses
    Table 119. Honz Pharmaceutical Basic Information, Area Served and Competitors
    Table 120. Honz Pharmaceutical Major Business
    Table 121. Honz Pharmaceutical Systemic Antifungals Product and Services
    Table 122. Honz Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 123. Honz Pharmaceutical Recent Developments/Updates
    Table 124. Honz Pharmaceutical Competitive Strengths & Weaknesses
    Table 125. Medisan Basic Information, Area Served and Competitors
    Table 126. Medisan Major Business
    Table 127. Medisan Systemic Antifungals Product and Services
    Table 128. Medisan Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 129. Medisan Recent Developments/Updates
    Table 130. Chengdu Brilliant Pharmaceutical Basic Information, Area Served and Competitors
    Table 131. Chengdu Brilliant Pharmaceutical Major Business
    Table 132. Chengdu Brilliant Pharmaceutical Systemic Antifungals Product and Services
    Table 133. Chengdu Brilliant Pharmaceutical Systemic Antifungals Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 134. Global Key Players of Systemic Antifungals Upstream (Raw Materials)
    Table 135. Systemic Antifungals Typical Customers
List of Figure
    Figure 1. Systemic Antifungals Picture
    Figure 2. World Systemic Antifungals Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Systemic Antifungals Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Systemic Antifungals Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Systemic Antifungals Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Systemic Antifungals Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Systemic Antifungals Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Systemic Antifungals Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Systemic Antifungals Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Systemic Antifungals Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Systemic Antifungals Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Systemic Antifungals Revenue (2018-2029) & (USD Million)
    Figure 13. Systemic Antifungals Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Systemic Antifungals Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Systemic Antifungals Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Systemic Antifungals Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Systemic Antifungals Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Systemic Antifungals Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Systemic Antifungals Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Systemic Antifungals Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Systemic Antifungals Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Systemic Antifungals Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Systemic Antifungals by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Systemic Antifungals Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Systemic Antifungals Markets in 2022
    Figure 27. United States VS China: Systemic Antifungals Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Systemic Antifungals Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Systemic Antifungals Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Systemic Antifungals Market Size Market Share by Type in 2022
    Figure 31. Injections
    Figure 32. Oral
    Figure 33. World Systemic Antifungals Market Size Market Share by Type (2018-2029)
    Figure 34. World Systemic Antifungals Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Systemic Antifungals Market Size Market Share by Application in 2022
    Figure 36. Hospital
    Figure 37. Clinic
    Figure 38. Drugstores
    Figure 39. Others
    Figure 40. Systemic Antifungals Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Companies Mentioned

MSD
Pfizer
Astellas Pharma
Gilead Sciences
Merck
Bayer
Novartis
Liposome Company
Xian-janssen
CR Pharma
Chiatai Tianqing
Haisco Pharmaceutical
Zhuhai Ebang Pharmaceutical
Livzon Group Livzon Pharmaceutical Factory
Honz Pharmaceutical
Medisan
Chengdu Brilliant Pharmaceutical